Vargatef – Nintedanib uses, dose and side effects
Vargatef capsules contain the active substance nintedanib. Nintedanib blocks the activity of a group of proteins involved in the formation of new blood vessels, which cancer cells need to get blood and oxygen. By blocking the activity of the proteins , nintedanib can stop the growth and spread of the cancer tumor.
Read MoreOfev – Nintedanib uses, dose and side effects
Ofev contains the active substance nintedanib, a drug belonging to the group of so-called tyrosine kinase inhibitors, and is used to treat idiopathic pulmonary fibrosis (IPF), other chronic fibrotizing interstitial lung diseases (ILDs) that are exacerbated (with progressive disease progression) and systemic sclerosis-systemic sclerosis. lung disease (SSc-ILD) in adults.
Read More